Search the Archive

Medicine: Schizophrenia / Clozaril #125897

ABC Evening News for Wednesday, Nov 21, 1990
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Diane Sawyer) Report introduced.

(Washington: George Strait) Controversy over limited access schizophrenic patients have to drug clozaril due to its cost examined. [Patient Kevin BLAKE - comments on what drug does for his schizophrenia.] Costly monitoring system by drug's manufacturer explained. [Sandoz Pharmaceuticals Corporation Dr. Gilbert HONIGFELD - comments.] Critics noted accusing Sandoz of price gouging. [Association of State Mental Health Directors Dr. Herndon HARDING, HONIGFELD - offer differing opinions on cost of clozaril program.] [Senator David PRYOR - talks about abuse of the drug system.]

Sawyer, Diane;
Strait, George

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.